Hyperbaric oxygen: Does it promote growth or recurrence of malignancy?

Undersea and Hyperbaric Medicine

Volumn 30, Issue 1, 2003, Pages 1-18

  Feldmeier, J ^a   Carl, U ^b   Hartmann, K ^c   Sminia, P ^d  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Diakoniekrankenhaus Rotenberg ^*  (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Carcinogenesis; Free radicals; Hyperbaric oxygen; Immune suppression; Metastasis

Indexed keywords

FREE RADICAL; GROWTH PROMOTOR;

ANIMAL; CELL CULTURE; CELLULAR IMMUNITY; HUMAN; HYPERBARIC OXYGEN; IMMUNOLOGICAL TOLERANCE; METABOLISM; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RAT; REVIEW; TUMOR RECURRENCE; WOUND HEALING;

ANIMALS; FREE RADICALS; GROWTH SUBSTANCES; HUMANS; HYPERBARIC OXYGENATION; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MICE; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 0037927890     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. 60Co therapy and hyperbaric oxygen. Proceedings of the third international congress on hyperbaric medicine. 1966;648-652.
2. Feldmeier JJ, Heimbach RD, Davolt DA, Brakora MJ. Hyperbaric oxygen and the cancer patient: A survey of practice patterns. Undersea Hyper Med 1993;20(4):337-345.
3. Feldmeier JJ. Hyperbaric oxygen: does it have a cancer causing or growth enhancing effect. In: Proceedings of the Consensus Conference sponsored by the European Society for Therapeutic Radiology and Oncology and the European Committee for Hyperbaric Medicine. Portugal 2001:129-146.
4. Kalns J, Krock L, Piepmeier E. The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res 1998;18:363-367.
5. Feldmeier JJ, Onoda JM, Bossung DE, Court WS, Alecu R. Effect of Hyperbaric oxygen on cancer cell metastatic potential and proliferation.(abs) Undersea Hyper Med 1997;24(supl):125.
6. Xu X, Yi H, Suzuki H, Kobayashi S, takahashi H, Nakashima I. Differential sensitivities to hyperbaric oxygen of lymphocyte subpopulations of normal and autoimmune mice. Immunology Letters 1997;59:79-84.
7. Brenner I, Shephard RJ, Shek PN. Immune function in hyperbaric environments, diving and decompression. Undersea Hyper Med 1999;26:27-39.
8. Feldmeier JJ, Boswell RN. Brown M, Shaffer P. The effects of hyperbaric oxygen on the inununological status of healthy human subjects. In: Kindwall EP. ed. Proceedings of the eighth international congress on hyperbaric medicine. San Pedro, CA: Best Publishing Co, 1987:41-46.
9. Lash GE, Postovit LM, Matthews NE, Chung EY, Canning MT, Pross H Adams MA, Graham CH. Oxygen as a regulator of cellular phenotypes in pregnancy and cancer. Can J Physiol Pharmacol 2002;80(2):103-9
10. Kaelin CM, Im MJ, Myers RAM, Manson PN, Hoopes JE. The effects of hyperbaric oxygen on free flaps in rats. Arch Surg 1990; 125:607-609.
11. Zamboni WA, Roth AC, Russel RC, Nemiroff PM, Casas L, Smoot EC. The effects of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg 1989; 5:343-347.
12. Monstrey SJ, Mullick P, Narayanan K, Ramasastry SS. Hyperbaric oxygen therapy and free radical production: an experimental study in doxorubicin (Adriamycin) extravasation injuries. Annals of Plastic Surgery 1997;38(2): 163-168.
13. Elayan IM, Axley MJ Prassad PV, Ahlers ST Auker CR. Effect of hyperbaric oxygen treatment on nitric oxide and oxygen free radicals in rat brain. Journal of Neurophysiology 2000;83(4):2022-2029.
14. Ceruti PA. Prooxidant states and tumor promotion. Science 1985;227(4685):375-381.
15. Heston WE, Pratt AW. Effect of concentration of oxygen on occurrence of pulmonary tumors in strain A mice. J Nat Cancer Inst 1959;22:707-717.
16. Sturrock JE, Nunn JF. Chromosomal damage and mutations after exposure of Chinese hamster cells to high concentrations of oxygen. Mutation Res 1978;57:27-33.
17. Dennog C, Gedik C, Wood S, Speit G. Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment. Mutation Research 1999;431(2):351-359.
18. Rothfuss A, Merk O, Radermacher P, Speit G. Evaluation of mutagenic effects of hyperbaric oxygen (HBO) in vitro II. Induction of oxidative DNA damage and mutations in the mouse lymphoma assay. Mutation Research 2000;471:87-94.
19. Speit G, Dennog C, Radermacher P, Rothfuss A. Genotoxicity of hyperbaric oxygen. Mutat Res 2002;512(2-3):111-9.
20. Bruyninckx WJ, Mason HS, Morse SA. Are physiologic oxygen concentrations mutagenic? Nature 1978; 274: 606-607.
21. McCredie JA, Inch WR, Kruen J, Watson T A. Effects of hyperbaric oxygen on growth and metastases of the C3H BA tumor in the mouse. Cancer 1966; 19:1537-1542.
22. Suit HD, Smith J, Suchato C. Effect of daily exposure to high pressure oxygen on tumor growth. Am J Roentgenol 1966; 97:1019-1022.
23. DeCosse II, Rogers LS. Effect of hyperbaric oxygen and cancer chemotherapy on growth of animal tumors. Cancer Res 1966; 26:287-291.
24. Johnson RE, Kagan AR, Bryant TL. Hyperbaric oxygen effect on experimental tumor growth. Radiology 1967; 88:775-777.
25. Dettmer CM, Kramer S, Gottlieb SF, Aponte GE, Driscoll MA. The effect of increased oxy- gen tensions upon animal tumor growth. JNCI 1968; 41:804-810.
26. Evans JC. Metastasis following radiotherapy in hyperbaric oxygen Radiol 1971; 22:538-540.
27. Feder B B, Stein JJ, Smith TK, Schaeflein JW, Boutelle JL, Conroy RM. The effect of hyperbaric oxygen on pulmonary metastases in C3H mice. Radiology 1968; 90: 1181-1184.
28. Johnson RJR, Wiseman N, Lauclan SC. The effect of hyperbaric oxygen on tumor metastases in mice. Clin Radiol 1971; 22: 538-540.
29. Shewell J, Thompson SC. The effect of hyperbaric oxygen treatment on pulmonary metastasis in the C3H mouse. Eur J Cancer 1980; 16:253-259.
30. Marx RE, Johnson RP. Problem wounds in oral and maxillofacial surgery; the role of hyperbaric oxygen. In: Problem Wounds-The Role of oxygen. JC Davis and TK Hunt (Eds.) New York, Elsevier, 1988; Chapter 4: 107-109.
31. Frid IA, Sapov IA, Katyshev AV, Lupanov AI, Rudakov VF, Semiachkina SO, Shul'ga NI. Effects of hyperbaric oxygenation on tumor growth. Vopr Onkol 1989; 35(8): 970-973.
32. McMillan T, Calhoun KH, Mader JT, Stiernberg CM, Rajarman S. The effect of hyperbaric oxygen on oral mucosal carcinoma. Laryngoscope 1989; 99:241-244.
33. Mestrovic J, Kousta D, Gosovic S, Denoble P, Radojkovic M, Angjelinovic S, Basic I, Marusic M. Suppression of rat tumor colonies in the lung by oxygen at high pressure is a local effect. Clin Exp Metastasis 1990; 8(2): 113-119.
34. Headley DB, Gapany M, Dawson DE, Kruse GD, Robinson RA, McCabe BF. The effect of hyperbaric oxygen on growth of human squamous cell carcinoma xenografts. Arch Otolaryngol Head Neck Surg 1991; 117(11): 1269-1272.
35. Sklizovic D, Sanger JR, Kindwall EP, Fink JG, Grunert BK, Campbell BH. Hyperbaric oxygen therapy and squamous cell carcinoma cell line growth. Head Neck 1993; 15 (3): 236-240.
36. Lyden E Granstrom G, Cvetkovska E, Nilsson J, Westin T, Edstrom S. Cell proliferative modulation of MCG 101 sarcoma from mice exposed to hyperbaric oxygenation. Undersea Hyperb Med 1997; 24: 123-129.
37. Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furuyama N, Naksjima N. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in indivdual organs. Cancer Chemother Pharmacol 2001; 47(1): 11-14.
38. VandenBrenk HAS, Madigan JP, Kerr RC. An analysis of the progression and development of metastases in patients receiving x-radiation in hyperbaric oxygen. Clin Radiol 1967; 18:54-61.
39. Cade IS, McEwen JB. Megavoltage radiotherapy in hyperbaric oxygen. Cancer 1967; 20:817-821.
40. Johnson RJR, Walton RJ. Sequential study of the effect of the addition of hyperbaric oxygen on the 5-year survival rates of carcinoma of the cervix treated with conventional radiation fractions. Am J Roentgenol Radium Ther Nucl Med 1974; 120:111-117.
41. Henk JM, Kunkler PB, Smith CW. Radiotherapy and hyperbaric oxygen in head and neck cancer: final report of first controlled clinical trial. Lancet 1977; July:101-103.
42. Henk JM, Kunkler PB, Smith CW. Radiation therapy and hyperbaric oxygen in head and neck cancer: interim report of second clinical trial. Lancet 1977; July:104-108.
43. Bennett MB, Sealy R, Hockly J. The treatment of stage III squamous cell carcinoma of the cervix in air and in hyperbaric oxygen. In: Smith G, ed. Proceedings of the sixth international congress on hyperbaric medicine. Scotland: Aberdeen University Press, 1977:247-252.
44. Perrins DJD, Wiernik G. Controlled trials in carcinoma of the bladder. In: Smith G, ed. Proceedings of the sixth international congress on hyperbaric medicine. Scotland: Aberdeen University Press, 1977:253-258.
45. Watson ER, Halnan KE, Dische S, et al. Hyperbaric oxygen and radiotherapy: a medical research council trial in carcinoma of the cervix. Br J Radiol 1978; 51: 879-887.
46. Dische S. Hyperbaric oxygen. The medical research council trials and their clinical significance. Br J Radiol 1979; 51:888-894.
47. Brady LW, Plenk HP, Hanley JA, Glassburn JR, Kramer S, Parker RG. Hyperbaric oxygen therapy for carcinoma of the cervix stages IIB, IIIA, IIIB, and IV A. Results of a randomized study by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 1981; 7: 991-998.
48. Eltorai I, Hart GB, Strauss MB, Khonsari F, Montroy RE. Does hyperbaric oxygen provoke an occult carcinoma in man? In: Kindwall EP, ed. Proceedings of the eighth international congress on hyperbaric medicine. San Pedro, CA: Best Publishing, 1987:18-29.
49. Denham W, Yeoh EK, Ward GG, Ahmad AS, Harvey NDM. Radiation therapy in hyperbaric oxygen for head and neck cancer at Royal Adelaide Hospital 1964-1969. Int J Radiat Oncol Biol Phys 1987; 13: 201-208.
50. Bradfield JJ, Kinsella JB, Mader JT, Bridges EW, Calhoun KH. Rapid progression of head and neck squamous carcinoma after hyperbaric oxygen. Otolaryngol Head Neck Surg 1996; 114: 793-797.
51. Marx RE. Radiation injury to tissue. In: Kindwall EP, Whelan HT (eds) Hyperbaric Medicine Practice (Second Edition). Flagstaff, AZ: Best Publishing Co., 1999; 720.
52. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-1186.
53. Jones, PH and Harris, AI. The Current Status of Clinical Trials in Anti- angiogenesis PPO Updates, Principles and Practice of Oncology 2000; 14(1):1-9.
54. Folkman, J. Fighting Cancer by Attacking its Blood Supply. Scientific American, September 1996, 150-154.
55. th Edition Holland, Frei, Bast, Kufe, Morton and Weichselbaum eds, Williams&Wilkins, Baltimore, 1997, 181-204.
56. Folkman, J. Antiangiogenic Therapy In: Cancer: Principles and Practice of Oncology, Devita, VT, Hellman, S, Rosenberg, S eds. Lippincott-Raven, Philadelphia 1997:3075-3085.
57. Hunt TK. The physiology of wound healing. Annals of Emergency Medicine 1988; 17: 1265-1273.
58. Knighton, DR. Mechanisms of Wound Healing In: Hyperbaric Medicine Practice, Kindwall, EP ed., Best, Flagstaff, 1995, 119-140.
59. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001;70:478-90.
60. Davis, JC, Buckley CJ, Barr PO. Compromised Soft Tissue Wounds Correction of Wound Hypoxia In:Problem Wounds:The Role of Oxygen, Davis, JC and Hunt, TK eds. Elsevier, New York, 1988, 143-152.
61. th Edition Holland, Frei, Bast, Kufe, Morton and Weichselbaum eds, Williams&Wilkins, Baltimore, 1997, 533-555.
62. Shweiki D, Itin A, Soffer, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 1992;359:843-848.
63. Minchenko A, Bauer T, Salceda S, Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo, Lab Invest, 1994;71:374-379.
64. Mulkhapadhyay D, Tsiokas L, Zhou X-MZ, Foster D, Brugge JS, Sukahatme VP. Hypoxic induction of human vascular endothelial growth factor through c-Src activation. Nature 1995;375:577-581.
65. Leith JT, Michelson S. Secretion rates and levels of vascular endothelial growth factor in clones of HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif 1995; 28: 415-430.
66. Rolfstad EK, Danielsen T. Hypoxia-induced metastasis of human melanoma cells:involvement of vascular endothelial growth factor-mediated angiogenesis. Br J of Cancer 1999;80:1697-1707
67. Chiarotto JA and Hill RP. A quantitative analysis of reduction in oxygen levels required to induce up-regulation of VEGF mRNA in cervical cancer cell lines, British Journal of Cancer, 1999; 80(10):1518-1524.
68. Desbaillets I, Diserens A, Tribolet N, Hamou M, Van Meir EG. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 1999; 18: 1447-1456.
69. Shi Q, Abbtuzzese JL, Huang S, Fidler IJ, Xiong Q Xie K. Constitutive and inducible interleukin 8 exprsession by hypoxia and acidosis renders human pancreatic cells more tumorigenic and metastatic. Clinical Cancer Res 1999;5:3711-3721.
70. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H-J, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285:245-248.
71. Hill RP, De Jaeger K, Jang A, Cairns R. pH, hypoxia and metastasis. Pub In: The Tumour environment:Causes and Consequences of Hypoxia and Acidity. 2001; Wiley, Chichester (Novartis Foundation Symposium):154-68
72. Niizeki H, Kobayashi M, Horiuchi I, Akakura N, Chen J, Wang J, Hamada J-I, Seth P, Katoh H, Watanabe H, Raz A, Hosokawa M. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells. Br J of Cancer 2002;86:1914-9.
73. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment, Cancer Research 1996;56:5754-5757.
74. Teicher BA. Physiologic mechanisms of therapeutic resistance: blood flow and hypoxia. Hematology/Oncology Clinics of North America 1995;9:475-506.
75. Vaupel P, Kelleher DK, Hoeckel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28:29-35.
76. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature, 1996;379:88-91.
77. Churchill-Davidson I. The oxygen effect in radiotherapy-historical review. Front Radiat Ther One 1968; 1:1-15.
78. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic cells. Cancer Research 1981; 41:73-81.
79. Rice GC, Hoy C, Schimke RT. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells, Proc Natl Acad Sci, 1986;83:5978-5982.
80. Hoeckel M, Knoop C, Schlenger K Vorndan B, Knapstein PG, Vaupel P. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Oxygen Transport to Tissue XV. Vaupel P (ed.) Plenum Press, New York. 1994: 445-450.
81. Gatenby RAA, Kessler HBB, Rosenblum JSS, Coia LRR, Moldofsky PJJ, Hartz WHH, Broder GJJ. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy, Int J Radiat Oncol Bio Phys 1988;14:831-838.
82. Brizel DM et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma, Cancer Research, 1996;56:941-943.